Company Filing History:
Years Active: 2013
Title: Kelly Bethel: Innovator in Cancer Detection
Introduction
Kelly Bethel is a prominent inventor based in San Diego, CA. She has made significant contributions to the field of cancer research, particularly in the detection of circulating tumor cells. Her innovative work aims to improve early-stage detection and diagnosis of cancer, ultimately enhancing patient outcomes.
Latest Patents
Kelly Bethel holds a patent for "Methods for the detection of circulating tumor cells." This invention provides methods for revealing, detecting, and analyzing circulating tumor cells in the blood of a subject. The ability to detect these cells allows for early-stage diagnosis and long-term prognosis in cancer patients. Additionally, her methods enable robust detection and clinically meaningful analysis of low volume samples, making them suitable for clinical settings and innovative cancer treatment approaches.
Career Highlights
Kelly is affiliated with The Scripps Research Institute, where she continues her groundbreaking work in cancer detection. Her research has the potential to transform how clinicians approach cancer diagnosis and treatment.
Collaborations
She has collaborated with notable colleagues, including Peter Kuhn and John H. Griffin, who share her commitment to advancing cancer research.
Conclusion
Kelly Bethel's contributions to cancer detection through her innovative patent highlight her role as a leading inventor in the field. Her work not only aids in early diagnosis but also paves the way for improved treatment options for cancer patients.